bpc 157 rheuma BPC-157 Peptide Therapy | Regenerative Medicine Are there concerns with the

Those differences trace back to molecular structure, which determines everything downstream

BPC-157 human data consists of three small studies totaling fewer than 30 participants

In general, these classes of medications heighten the risk for the following: High blood pressure/ cardiovascular disease Blood clot formation/ thromboembolism/pulmonary embolism High cholesterol/ dyslipidemia Heart disease Type 2 diabetes Weight gain Certain types of cancers (primarily breast and prostate cancer) Infertility/Interfertility Hepatic toxicity Contraindications As with any use of long-term hormonal therapy and associated treatments, a screening process should be in place to ascertain if the patient is appropriate for GAHT

Nass R, Pezzoli SS, Oliveri MC, et al